4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
US10196354B2 · kind B2 · utility
2Cited by
14References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2017 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Jul 12, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds according to Formula I (Formula I), and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.